FTC Imposes Conditions on UnitedHealth Group’s Proposed Acquisition of DaVita Medical Group

Healthcare provider and insurer UnitedHealth Group Incorporated and healthcare provider DaVita, Inc. have agreed to a settlement to resolve Federal Trade Commission allegations that UnitedHealth Group’s proposed $4.3 billion acquisition of DaVita’s DaVita Medical Group will harm competition in healthcare markets in Clark and Nye Counties, Nevada. Under the proposed settlement, no later than 40 […]

Statement of Federal Trade Commission Concerning Its Vote to Close the Investigation of a Proposed Transaction Combining Massachusetts Healthcare Providers

The Federal Trade Commission has issued a statement on its vote to close the investigation of a proposed transaction that would combine general acute care hospitals, a psychiatric hospital, and physician practices in eastern Massachusetts. CareGroup, Inc. (the parent company of Beth Israel Deaconess Medical Center, Inc., Mount Auburn Hospital, and New England Baptist Hospital) proposes […]

FTC Approves Fresenius Medical Care AG’s Application for Approval of Proposed Plan to Establish New Outpatient Hemodialysis Clinic

The Federal Trade Commission has approved an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic in Wyoming, Michigan at a location previously divested by Fresenius. The application is related to the FTC’s complaint and proposed order, announced on February 28, 2012, allowing Fresenius’s proposed acquisition of Liberty […]

FTC Requires Kidney Dialysis Chain DaVita, Inc. to Divest Assets as a Condition of Acquiring Competitor Renal Ventures Management LLC

The Federal Trade Commission will require the national outpatient kidney-dialysis chain DaVita, Inc. to divest its ownership interest in seven clinics – five in suburban and urban areas of New Jersey and two on the outskirts of Dallas, Texas – as part of a settlement resolving charges that its $358 million acquisition of competitor Renal […]